A carregar...

Low-frequency KRAS mutations are prevalent in lung adenocarcinomas

AIM: This study quantified low-frequency KRAS mutations in normal lung and lung adenocarcinomas, to understand their potential significance in the development of acquired resistance to EGFR-targeted therapies. MATERIALS & METHODS: Allele-specific Competitive Blocker-PCR was used to quantify KRAS...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Per Med
Main Authors: Myers, Meagan B, McKim, Karen L, Meng, Fanxue, Parsons, Barbara L
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5084916/
https://ncbi.nlm.nih.gov/pubmed/27795727
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/pme.14.69
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!